| Drug Name | Dupilumab |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Safety communication
|
| Specialty (Theraputic area) |
Dermatology
|
| Risk |
Psoriasis |
| safety communication |
|